bioRxiv/medRxiv TRiP Review Activity

6,525 Reviews — eLife — All Subjects

Most recent first Previous |  Page 405: Articles 4041-4050  | Next

Hepatic inactivation of murine Surf4 results in marked reduction in plasma cholesterol
Tang, V. T., McCormick, J., Xu, B., Wang, Y., Fang, H., Wang, X., Siemieniak, D., Khoriaty, R., Emmer, B. T., Chen, X.-W., Ginsburg, D.
10.1101/2022.08.01.502222 — Posted: 2022-08-03 — Discussion: 2022-09-22  eLife
The causal effects of body mass index (BMI) on childhood symptoms of depression, anxiety disorder, and attention-deficit hyperactivity disorder: a within family Mendelian randomization study
Hughes, A. M., Morris, T. T., Ayorech, Z., Tesli, M., Ask, H., Reichborn-Kjennerud, T., Andreassen, O. A., Magnus, P., Helgeland, O., Johansson, S., Njolstad, P. R., Davey Smith, G., Havdahl, A., Howe, L. D., Davies, N. M.
10.1101/2021.09.17.21263612 — Posted: 2021-09-22 — Discussion: 2022-09-22  eLife
Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Galvez, N. M. S., CoronaVacCL03 Study Group, , Pacheco, G. A., Schultz, B. M., Melo-Gonzalez, F., Soto, J., Duarte, L. F., Gonzalez, L. A., Rivera, D. S., Rios, M., Berrios, R. V., Vazquez, Y., Moreno-Tapia, D., Vallejos, O. P., Andrade, C. A., Hoppe-Elsholz, G., Iturriaga, C., Urzua, M., Navarrete, M. S., Rojas, A., Fasce, R., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverria, F., Soto-Rifo, R., Weiskopf, D., Grifoni, A., Sette, A., Zeng, G., Meng, W., Gonzalez-Aramundiz, J. V., Goldblatt, D., Gonzalez, P. A., Abarca, K., Bueno, S. M., Kalergis, A. M.
10.1101/2022.08.05.22278464 — Posted: 2022-08-08 — Discussion: 2022-09-22  eLife
Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis
Wong, A. I., Beites, T., Planck, K. A., Li, S., Poulton, N. C., Rhee, K., Schnappinger, D., Ehrt, S., Rock, J. M.
10.1101/2022.07.07.499113 — Posted: 2022-07-07 — Discussion: 2022-09-20  eLife
Chronic Ca2+ imaging of cortical neurons with long-term expression of GCaMP-X
Geng, J., Li, W., Tang, Y., Gao, Y., Lu, Y., Li, P., Li, X., Wang, P., Fan, Y., Yang, Y., Guo, Z., Liu, X.
10.1101/2022.01.09.475579 — Posted: 2022-01-11 — Discussion: 2022-09-18  eLife
EZ Clear for simple, rapid, and robust mouse whole organ clearing
Hsu, C.-W., Cerda, J., Kirk, J. M., Turner, W. D., Rasmussen, T. L., Dickinson, M. E., Suarez, C. P. F., Wythe, J.
10.1101/2022.01.12.476113 — Posted: 2022-01-13 — Discussion: 2022-09-18  eLife
Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq
Vazquez, S. E., Mann, S. A., Bodansky, A., Kung, A. F., Quandt, Z., Ferre, E. M. N., Landegren, N., Eriksson, D., Bastard, P., Zhang, S.-Y., Liu, J., Mitchell, A., Mandel-Brehm, C., Miao, B., Sowa, G., Zorn, K., Chan, A. Y., Shimizu, C., Tremoulet, A., Lynch, K., Wilson, M. R., Kämpe, O., Dobbs, K., Delmonte, O. M., Notarangelo, L. D., Burns, J. C., Casanova, J.-L., Lionakis, M. S., Torgerson, T. R., Anderson, M. S., DeRisi, J. L.
10.1101/2022.03.23.485509 — Posted: 2022-03-25 — Discussion: 2022-09-18  eLife
Targeting RNA:Protein Interactions with an Integrative Approach Leads tothe Identification of Potent YB-1 Inhibitors
El Hage, K., Babault, N., Maciejak, O., Desforges, B., Craveur, P., Steiner, E., Rengifo-Gonzalez, J. C., Henri, H., Clement, M.-J., Joshi, V., Bouhss, A., Wang, L., Bauvais, C., Pastre, D.
10.1101/2022.04.08.487452 — Posted: 2022-04-10 — Discussion: 2022-09-18  eLife
Inhibited KdpFABC resides in an E1 off-cycle state
Silberberg, J., Stock, C., Hielkema, L., Corey, R. A., Rheinberger, J., Wunnicke, D., Dubach, V., Stansfeld, P., Haenelt, I., Paulino, C.
10.1101/2022.06.19.496728 — Posted: 2022-06-19 — Discussion: 2022-09-18  eLife
Kinesin-1, -2 and -3 motors use family-specific mechanochemical strategies to effectively compete with dynein during bidirectional transport
Gicking, A. M., Ma, T.-C., Feng, Q., Jiang, R., Badieyan, S., Cianfrocco, M. A., Hancock, W. O.
10.1101/2022.08.04.502809 — Posted: 2022-08-05 — Discussion: 2022-09-18  eLife

Evaluation Sources